Form 8-K - Current report:
SEC Accession No. 0001232524-20-000015
Filing Date
2020-02-25
Accepted
2020-02-25 16:09:32
Documents
16
Period of Report
2020-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a4q19form8-k.htm   iXBRL 8-K 52964
2 EXHIBIT 99.1 a4q19financialpr.htm EX-99.1 616069
8 jazzpharmalogo2.jpg GRAPHIC 588601
  Complete submission text file 0001232524-20-000015.txt   1662847

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20200225.xsd EX-101.SCH 4575
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20200225_cal.xml EX-101.CAL 612
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20200225_def.xml EX-101.DEF 1462
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20200225_lab.xml EX-101.LAB 28168
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20200225_pre.xml EX-101.PRE 14576
13 EXTRACTED XBRL INSTANCE DOCUMENT a4q19form8-k_htm.xml XML 5035
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 20650688
SIC: 2834 Pharmaceutical Preparations